Advantages of using 5% hypertonic saline nebulization over 3% saline nebulization in children with Acute Bronchiolitis

Comparison of 3% vs 5% Hypertonic Saline Nebulization in Acute Bronchiolitis- A randomized Clinical Trial.

Status

Recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2017/08/009351

Enrollment

Registered

2017-08-11

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- acute bronchiolitis

Interventions

Intervention1: 5% saline: 4 ml of 3% saline nebulisation every 4 hrly till discharge Intervention2: 5 % saline: 4ml 5 % saline nebulisation every 4 hrly Control Intervention1: 3% saline: 4ml 5 % salin

Eligibility

Inclusion criteria

Inclusion criteria: 2 months to 2 years children with acute bronchiolitis

Exclusion criteria

Exclusion criteria: children with heart disease

Design outcomes

Primary

Measure	Time frame
assessment of severity of bronchiolitisTimepoint: 0 hrs, 24 hrs	—

Secondary

Measure	Time frame
the duration of hospital stayTimepoint: 0 hrs, 24 hrs, 48 hrs	—

Countries

India

Contacts

Public ContactDr Mayur Prakash

Department of Paediatrics

drnbiswal@yahoo.com09442528402

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026